Axogen, Inc.
AXGNElectromedical & Electrotherapeutic Apparatus · SIC 3845 · CIK 0000805928
Revenue FY2025
$225.0M
Net Income
$(16.0M)
EPS (Basic)
$-0.34
Net Margin
-7.0%
ROE
-12.2%
Total Equity
$129.0M
Shares Out
54M
Axogen, Inc. — Electromedical & Electrotherapeutic Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 5 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Holocene Advisors
Holocene Advisors
$24.8M
0.0%
(3.1%)
Royce & Associates
Royce & Associates
$3.3M
0.0%
(36.1%)
WCM Investment Management
WCM Investment Management
$15.1M
0.0%
(39.8%)
First Eagle Investment Management
First Eagle
$15.8M
0.0%
(3.8%)
Mairs & Power
Mairs & Power
$1.0M
0.0%
—
Insider Transactions
Reading stored insider transactions…